In the UK, about 1 in 8 men will be diagnosed with prostate cancer in their lifetime. We don't know exactly what causes prostate cancer but there are some things that may mean you are more likely to get it – these are called risk factors.
There are three main risk factors for getting prostate cancer, which are things you can't change. These are:
If you have any of these risk factors or if you have any symptoms, speak to your GP. They can talk to you about your risk, and about the tests that are used to diagnose prostate cancer. You can also get in touch with our Specialist Nurses, who can help you understand your individual risk of prostate cancer.
See and share our infographic on prostate cancer risk factors.
Prostate cancer mainly affects men over 50, and your risk increases as you get older. The most common age for men to be diagnosed with prostate cancer is between 65 and 69 years. You can get prostate cancer at any age but if you are under 50, your risk of getting prostate cancer is very low but it is possible.
If you're over 50 and you're worried about your risk of prostate cancer, you might want to ask your GP about tests for prostate cancer. If you're over 45 but have a higher risk of prostate cancer – because you have a family history of prostate cancer or you're a black man – you might want to talk to your GP too.
Our Specialist Nurses can also help you understand your risk of getting prostate cancer.
Your family history is information about any health problems that have affected your family. Families have many common factors, such as their genes, environment and lifestyle. Together, these factors can help suggest if you are more likely to get some health conditions.
Inside every cell in our body is a set of instructions called genes. These are passed down (inherited) from our parents. Genes control how the body grows, works and what it looks like. If something goes wrong with one or more genes (known as a gene fault or mutation), it can sometimes cause cancer.
If people in your family have prostate cancer or breast cancer, it might increase your own risk of getting prostate cancer. This is because you may have inherited the same faulty genes.
Although prostate cancer can run in families, having a family history doesn’t mean you will get it. But it's important to speak to your GP if you have any relatives with prostate cancer or breast cancer, as your risk of hereditary prostate cancer may be higher.
Do you have a family history of prostate cancer?
If you're over 45 and your father or brother has had prostate cancer, you may want to talk to your GP. Our Specialist Nurses can also help you understand your hereditary risk of prostate cancer.
Black men are more likely to get prostate cancer than other men. We don’t know why, but it might be linked to genes. In the UK, about 1 in 4 black men will get prostate cancer in their lifetime.*
If you have mixed black ethnicity, you are likely to be at higher risk of prostate cancer than a white man. But we don’t know your exact risk because we don’t have enough information on prostate cancer in men with mixed black ethnicity. And we don’t know whether it makes a difference if it’s your mother or father who is black.
If you're a black man and you're over 45, speak to your GP about your risk of prostate cancer, even if you don't have any symptoms. Remember to tell them if you have a family history of prostate cancer or breast cancer. You can also contact our Specialist Nurses.
Read more about the risk in black men.
*This statistic was worked out using information about men recorded as ‘black African’, ‘black Caribbean’ and ‘black other’.
No one knows how to prevent prostate cancer, but a healthy lifestyle may be important.
Being overweight may increase your risk of being diagnosed with prostate cancer that’s aggressive (more likely to spread) or advanced (cancer that has spread outside the prostate). Eating healthily and keeping active can help you stay a healthy weight.
Read more about diet, physical activity and prostate cancer risk.
Updated: August 2019 | To be reviewed: August 2021
• Allott EH, Masko EM, Freedland SJ. Obesity and Prostate Cancer: Weighing the Evidence. Eur Urol. 2013 May;63(5):800–9.
• Barber L, Gerke T, Markt SC, Peisch SF, Wilson KM, Ahearn T, et al. Family History of Breast or Prostate Cancer and Prostate Cancer Risk. Clin Cancer Res. 2018 Dec 1;24(23):5910–7.
• Cancer Research UK. Prostate cancer incidence statistics: Prostate cancer incidence by age (2011-2013) [Internet]. [cited 2018 Dec 12]. Available from: http://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/prostate-cancer/incidence
• Cancer Research UK. Cancer incidence for common cancers (2015) [Internet]. [cited 2018 Dec 12]. Available from: http://www.cancerresearchuk.org/health-professional/cancer-statistics/incidence/common-cancers-compared
• Cao Y, Ma J. Body Mass Index, Prostate Cancer-Specific Mortality, and Biochemical Recurrence: a Systematic Review and Meta-analysis. Cancer Prev Res (Phila Pa). 2011 Jan 13;4(4):486–501.
• Conti DV, Wang K, Sheng X, Bensen JT, Hazelett DJ, Cook MB, et al. Two Novel Susceptibility Loci for Prostate Cancer in Men of African Ancestry. JNCI J Natl Cancer Inst [Internet]. 2017 Aug 1 [cited 2019 Jan 3];109(8). Available from: https://academic.oup.com/jnci/article/doi/10.1093/jnci/djx084/3858844
• Cozar JM, Robles-Fernandez I, Martinez-Gonzalez LJ, Pascual-Geler M, Rodriguez-Martinez A, Serrano MJ, et al. Genetic markers a landscape in prostate cancer. Mutat Res Mutat Res. 2018 Jan;775:1–10.
• Discacciati A, Orsini N, Wolk A. Body mass index and incidence of localized and advanced prostate cancer--a dose-response meta-analysis of prospective studies. Ann Oncol. 2012 Jan 6;23(7):1665–71.
• Eeles R, Goh C, Castro E, Bancroft E, Guy M, Olama AAA, et al. The genetic epidemiology of prostate cancer and its clinical implications. Nat Rev Urol. 2014 Jan;11(1):18–31.
• Häggström C, Stocks T, Ulmert D, Bjørge T, Ulmer H, Hallmans G, et al. Prospective study on metabolic factors and risk of prostate cancer: Metabolic Factors and Prostate Cancer. Cancer. 2012 Dec 15;118(24):6199–206.
• Ho T, Gerber L, Aronson WJ, Terris MK, Presti JC, Kane CJ, et al. Obesity, Prostate-Specific Antigen Nadir, and Biochemical Recurrence After Radical Prostatectomy: Biology or Technique? Results from the SEARCH Database. Eur Urol. 2012 Nov;62(5):910–6.
• Jones AL, Chinegwundoh F. Update on prostate cancer in black men within the UK. Ecancermedicalscience. 2014;8:455.
• Kheirandish P, Chinegwundoh F. Ethnic differences in prostate cancer. Br J Cancer. 2011 Aug 9;105(4):481–5.
• Kiciński M, Vangronsveld J, Nawrot TS. An Epidemiological Reappraisal of the Familial Aggregation of Prostate Cancer: A Meta-Analysis. Little J, editor. PLoS ONE. 2011 Oct 31;6(10):e27130.
• Lamy P-J, Trétarre B, Rebillard X, Sanchez M, Cénée S, Ménégaux F. Family history of breast cancer increases the risk of prostate cancer: results from the EPICAP study. Oncotarget [Internet]. 2018 May 4 [cited 2019 Feb 15]; Available from: http://www.oncotarget.com/fulltext/25320
• Lloyd T, Hounsome L, Mehay A, Mee S, Verne J, Cooper A. Lifetime risk of being diagnosed with, or dying from, prostate cancer by major ethnic group in England 2008–2010. BMC Med [Internet]. 2015 Dec [cited 2015 Nov 5];13(1). Available from: http://www.biomedcentral.com/1741-7015/13/171
• Mucci LA, Hjelmborg JB, Harris JR, Czene K, Havelick DJ, Scheike T, et al. Familial Risk and Heritability of Cancer Among Twins in Nordic Countries. JAMA. 2016 Jan 5;315(1):68.
• Perez-Cornago A, Appleby PN, Pischon T, Tsilidis KK, Tjønneland A, Olsen A, et al. Tall height and obesity are associated with an increased risk of aggressive prostate cancer: results from the EPIC cohort study. BMC Med [Internet]. 2017 Dec [cited 2017 Dec 1];15(1). Available from: http://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-017-0876-7
• Rebbeck TR, Devesa SS, Chang B-L, Bunker CH, Cheng I, Cooney K, et al. Global Patterns of Prostate Cancer Incidence, Aggressiveness, and Mortality in Men of African Descent. Prostate Cancer. 2013;2013:1–12.
• Rebbeck TR. Prostate Cancer Genetics: Variation by Race, Ethnicity, and Geography. Semin Radiat Oncol. 2017 Jan;27(1):3–10.
• World Cancer Research Fund International. Continuous Update Project report: Diet, Nutrition, Physical Activity and Prostate Cancer [Internet]. 2014. Available from: www.wcrf.org/sites/default/files/Prostate-Cancer-2014-Report.pdf
• Miranda Benney, Cancer Clinical Programme Manager, University Hospitals Plymouth
• Simon Bott, Consultant Urologist, Frimley Health NHS Foundation Trust, Portsmouth
• Frank Chinegwundoh, Consultant Urological Surgeon, Barts Health NHS Trust, London
• Christopher Eden, Consultant Urological Surgeon, The Royal Surrey County Hospital, Guildford
• Our Specialist Nurses
• Our Volunteers.